Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at evaluate the efficacy of psilocybin on the symptom of anhedonia in individuals with treatment-resistant major depressive disorder for people with depression, Anhedonia, or Treatment Resistant Depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether questionnaires and follow-up can help people with Treatment Resistant Depression or Autism Spectrum Disorder. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a digital support tool can help people with Chronic Low-back Pain or Depression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is comparing Psilocybin with Full dose COMP360 with sham aiTBS rTMS for people with Treatment Resistant Depression, Mdd, depression, or Recurrent Depression. Participants receive Psilocybin or Full dose COMP360 with sham aiTBS rTMS and complete study visits and assessments.
This study is looking at whether a digital support tool can help people with Spinal Cord Injury, Depression - depression, or Veteran. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at see if one or two doses of psilocybin is more effective in relieving depressive symptoms in patients with treatment-resistant depression (TRD) for people with depression or Treatment-Resistant Depression. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether Psilocybin can help people with Depression, Anxiety, Psilocybin-Assisted Psychotherapy, or Advanced Cancer. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Psilocybin can help people with Psychological Stress, Depression, or Anxiety. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether questionnaires and follow-up can help people with Lung Non-Small Cell Carcinoma or Unipolar Depression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether questionnaires and follow-up can help people with Refractory Depression or Treatment Resistant Depression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Psilocybin can help people with Alcohol Use Disorder, Alcohol Dependence, Depression, or Anxiety. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Psilocybin 25 mg can help people with depression or Alcohol Use Disorder. Participants take part in Psilocybin 25 mg and complete follow-up assessments.